World Rural Health Conference
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2224
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents 
CASE REPORT
Year : 2014  |  Volume : 3  |  Issue : 1  |  Page : 86-88  

Recurrent pneumothorax in a young female with pulmonary lymphangiomyomatosis: A case report and overview of literature


Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha, Maharashtra, India

Date of Web Publication9-Apr-2014

Correspondence Address:
Vishakha V Jain
Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha - 442 102, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2249-4863.130336

Rights and Permissions
  Abstract 

Lymphangiomyomatosis (LAM) is a rare cystic interstitial lung disease that exclusively affects women of child bearing age and is associated with vascular proliferation of smooth muscle cells in the lung. We report a case of young female with pulmonary LAM presenting with recurrent pneumothorax.

Keywords: Cystic disease, lymphangiomyomatosis, pneumothorax, pulmonary


How to cite this article:
Jain VV, Gupta O P, Jajoo S, Khiangate B. Recurrent pneumothorax in a young female with pulmonary lymphangiomyomatosis: A case report and overview of literature. J Family Med Prim Care 2014;3:86-8

How to cite this URL:
Jain VV, Gupta O P, Jajoo S, Khiangate B. Recurrent pneumothorax in a young female with pulmonary lymphangiomyomatosis: A case report and overview of literature. J Family Med Prim Care [serial online] 2014 [cited 2019 May 21];3:86-8. Available from: http://www.jfmpc.com/text.asp?2014/3/1/86/130336


  Introduction Top


Pulmonary lymphangiomyomatosis (LAM) is a progressive lung disease that affects exclusively young women of child bearing age and is characterized by diffuse proliferation of abnormal smooth-muscle cells and cystic destruction of the lung parenchyma. Clinically, LAM is characterized by progressive dyspnea with exertion, fatigue, pneumothorax, chronic cough, wheezing and chestpain, chylothorax and an obstructive or mixed restrictive and obstructive pattern on pulmonary function tests. There are various therapeutic modalities for LAM with differing efficacy and lung transplantation remains the only therapeutic option for patients with advanced disease.


  Case Report Top


A 36-year-old female, non-smoker, presented to us with acute onset breathlessness and sudden onset right sided chest pain. Clinically she had tachypnea, tachycardia and hyper-resonant percussion note with decreased breath sounds on the right side of the chest. There was no evidence of digital clubbing, lymphadenopathy, oral ulcers or skin lesions. Cardiovascular examination was unremarkable and no organomegaly, masses or ascites were detectable in the abdomen. An X-ray chest was done, which showed a right sided pneumothorax with the collapse of lung and an intercostal tube was inserted. After 72 h of Inter costal drain (ICD) insertion her lung showed complete expansion with no air leak and she was symptomatically better. A repeat chest X-ray was done, which showed fully expanded right lung with bilateral cystic changes [Figure 1]a and b. A high resolution computerised tomography of chest (HRCT) was planned but due to economic reasons it could not be done and patient was discharged with advice to follow-up.
Figure 1: (a) A chest X‑ray with right sided pneumothorax. (b) A chest X‑ray of the same patient after 2 days with intercostal tube in situ and fully expanded right lung

Click here to view


After few days of discharge patient was readmitted with similar complaints of sudden onset breathlessness and right sided chest pain. Her examination findings were consistent with right sided pneumothorax, which was confirmed on X-ray chest [Figure 2]a. An ICD was reinserted. HRCT was done [Figure 3] which showed multiple well-defined diffusely distributed variable sized and irregular shaped cystic areas in bilateral lung fields present in both intraparenchymal and subpleural location with few nodules and increased linear interstitial markings with right pneumothorax, which were suggestive of cystic lung disease, probably LAM. Patient did not have evidence of any fluid in the pleural cavity. This time even after 72 h, patient did not have complete lung expansion and continued to have air leak [Figure 2]b. After 5 days, patient was referred to a Pulmonologist for further intervention.
Figure 2: (a) X‑ray chest of the same patient with second episode of right sided pneumothorax. (b) Chest X‑ray of the same patient with intercostal tube in situ and a partially expanded lung

Click here to view
Figure 3: High resolution computed tomography scan of the chest showing diffuse thin‑walled cystic changes of the pulmonary parenchyma and right‑sided pneumothorax with intercostal tube in situ, all findings characteristic of lymphangiomyomatosis

Click here to view



  Discussion Top


LAM is a rare cystic interstitial lung disease that exclusively affects women of child bearing age and is associated with vascular proliferation of smooth muscle cells in lung and cystic destruction of lungs. [1] LAM occurs in two main forms: Tuberous sclerosis complex (TSC)-associated LAM (TSC-LAM) and sporadic LAM (S-LAM). LAM occurs 30% in cases of TSC, but TSC-LAM constitute only 15% of patients of LAM. [1]

Patients with TSC-LAM have features of tuberous sclerosis in the form of central nervou s system hamartomas, developmental delay and cutaneous manifestations like ash-leaf macules, shagreen patches and seizures. S-LAM occurs in premenopausal women who present with progressive exertional dyspnea, chronic non-productive cough, spontaneous pneumothorax or chylothorax and is frequently associated with renal angiomyolipomas (AMLs). [2] Breathlessness being the most common symptom (75%) followed by spontaneous pneumothorax in 50% patients and chylothorax in 20% patients. Less common presenting features include hemoptysis and chyloptysis. Proliferation of smooth muscle in pulmonary lymphatics usually results in obstruction thus leading to chylothoraces. [1] Pneumothoraces occur in approximately 60-70% of LAM-patients with a recurrence rate of 70%, which is the highest among all chronic lung diseases. [3] Our case most probably would have been a S-LAM presenting with spontaneous recurrent pneumothorax and breathlessness.

In a case of LAM, a plain X-ray chest usually shows a hyperinflated lung with reticular or reticulonodular pattern. Cysts and bullae can be seen on plain X-ray chest, but their anatomical detailing can only be done on HRCT. [3],[4],[5] Various cystic lung disease can be clearly differentiated based on the type of cysts, pattern of distribution of cysts and other associated findings. [6]

It is a consensus that in presence of suitable clinical situation, HRCT finding suggestive of LAM is usually enough to clinch the diagnosis and a biopsy is not required for confirmation. Examples of such situations include patients who present with known TSC, recurrent pneumothorax, chylothorax or renal AML. Lung biopsy, generally through a video-assisted thoracoscopic approach, should be considered when there is doubt about the diagnosis or when there are one or more alternative diagnostic possibilities with different management. [1] Even in our case HRCT clinched the diagnosis in presence of clinical scenario.

Immunostaining with HBM-45, specific for smooth muscle components namely actin and desmin can be employed to improve sensitivity and specificity. [7]

LAM has been seen in premenopausal women, with oral contraceptive use, [2],[8] and incidence is increased in pregnancy. [9],[10] Hence estrogen has been implicated as having a role in its pathogenesis. In our case, the patient was a young women, pre-menopausal without a history of oral contraceptive use.Though in few reported cases of LAM in post-menopausal women the progression of disease has been slow. [11] LAM registry concluded that progesterone, oophorectomy and even , a partial estrogen receptor antagonist also appears to worsen the disease. [2]

According to the latest evidence even the first episode of pneumothorax in a case of LAM should be treated with pleurodesis, since it opens the possibility of recurrent pneumothoraces. [2]

However, it has been found that in cases that had received pleurodesis with talc, had intraoperative technical difficulties during lung transplantation due to severe hemorrhage caused either by pleural adhesions or disease itself. [12] However, there have been cases of successful lung transplantation after pleurodesis and it is no longer considered as an absolute contraindication.

Lung transplantation in patients of LAM is usually considered in view of recurrent refractory pneumothoraces, severe hypoxemia or declining lung function (FEV1 < 30% of predicted FEV1). Till date over 130 patients of LAM have received successful lung transplantation. [13],[14] Lung transplantation can be an effective treatment for end-stage LAM; however, LAM cell migration into the transplanted lung can result in recurrence. A recent study also showed that Sirolimus was an alternative drug for LAM. [15] Sirolimus has made its way into the treatment modality for LAM based on its action of inhibition of mammalian target of rapamycin (mTOR) pathway. Though Sirolimus is an established treatment in solid organ transplants there is fall side of its use in LAM due to its severe pulmonary toxicity. [16],[17]

LAM being a very rare disease and there are still many questions unanswered as to understanding the mechanism and progression of disease. But a case of recurrent spontaneous pneumothorax usually perplexes the primary care physician. Knowledge of LAM as a cause of spontaneous recurrent pneumothorax especially in young females would be helpful for primary care physician for diagnosis. It is also necessary to understand that early referral to Pulmonologist by primary care physician for pleurodesis may help the patient tremendously.

 
  References Top

1.McCormack FX. Lymphangioleiomyomatosis: A clinical update. Chest 2008;133:507-16.  Back to cited text no. 1
    
2.Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, et al. The NHLBI lymphangioleiomyomatosis registry: Characteristics of 230 patients at enrollment. Am J RespirCrit Care Med 2006;173:105-11.  Back to cited text no. 2
    
3.Spiliopoulos K, Tsantsaridou A, Papamichali R, Kimpouri K, Salemis NS, Koukoulis GK, et al. Recurrent spontaneous pneumothorax in a 42 years old woman with pulmonary lymphangioleiomyomatosis: Insights and pitfalls of the surgical treatment. J Clin Med Res 2013;5:70-4.  Back to cited text no. 3
    
4.Kirchner J, Stein A, Viel K, Dietrich CF, Thalhammer A, Schneider M, et al. Pulmonary lymphangioleiomyomatosis: High-resolution CT findings. EurRadiol 1999;9:49-54.  Back to cited text no. 4
    
5.Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999;115:1041-52.  Back to cited text no. 5
    
6.Hartmann TE. CT diagnosis of cystic lung diseases. RadiolClin North Am 2001;39:1231-43.  Back to cited text no. 6
    
7.Bonetti F, Chiodera PL, Pea M, Martignoni G, Bosi F, Zamboni G, et al. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J SurgPathol 1993;17:1092-102.  Back to cited text no. 7
    
8.Yano S. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment. Thorax 2002;57:1085-6.  Back to cited text no. 8
    
9.Yockey CC, Riepe RE, Ryan K. Pulmonary lymphangioleiomyomatosis complicated by pregnancy. Kans Med 1986;87:277-8, 293.  Back to cited text no. 9
    
10.Weinans MJ, van Loon AJ. A diagnosis of lymphangioleiomyomatosis in a pregnant woman presenting with a retroperitoneal mass. Br J ObstetGynaecol 1999;106:747-8.  Back to cited text no. 10
    
11.Baldi S, Papotti M, Valente ML, Rapellino M, Scappaticci E, Corrin B. Pulmonary lymphangioleiomyomatosis in postmenopausal women: Report of two cases and review of the literature. EurRespir J 1994;7:1013-6.  Back to cited text no. 11
    
12.Boehler A, Speich R, Russi EW, Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996;335:1275-80.  Back to cited text no. 12
    
13.O′Brien JD, Lium JH, Parosa JF, Deyoung BR, Wick MR, Trulock EP. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J RespirCrit Care Med 1995;151:2033-6.  Back to cited text no. 13
    
14.Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, et al. Recurrent lymphangiomyomatosis after transplantation: Genetic analyses reveal a metastatic mechanism. Am J RespirCrit Care Med 2003;167:976-82.  Back to cited text no. 14
    
15.Chachaj A, Drozdz K, Chabowski M, Dziegiel P, Grzegorek I, Wojnar A, et al. Chyloperitoneum, chylothorax and lower extremity lymphedema in woman with sporadic lymphangioleiomyomatosis successfully treated with sirolimus: A case report. Lymphology 2012;45:53-7.  Back to cited text no. 15
    
16.Yakupoglu YK, Kahan BD. Sirolimus: A current perspective. ExpClin Transplant 2003;1:8-18.  Back to cited text no. 16
    
17.Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant 2005;19:698-703.  Back to cited text no. 17
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
   
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Case Report
Discussion
References
Article Figures

 Article Access Statistics
    Viewed1911    
    Printed40    
    Emailed0    
    PDF Downloaded214    
    Comments [Add]    

Recommend this journal